Neoadjuvant chemotherapy for high‐risk prostatic adenocarcinoma

INTRODUCTION: Neoadjuvant chemotherapy in high‐risk, locally advanced prostate cancer remains an understudied area of prostate cancer. Chemotherapy continues to be a viable option. The combination with surgery may be desired but lacks data for complete recommendation. CASE PRESENTATION: We demonstra...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunner, Robert, Buck, Bradley, Giffen, Zane, Murtagh, Daniel, Lewis, Terrence, Gatto‐Weis, Cara, Sindhwani, Puneet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292178/
https://www.ncbi.nlm.nih.gov/pubmed/32743374
http://dx.doi.org/10.1002/iju5.12031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292178/
https://www.ncbi.nlm.nih.gov/pubmed/32743374
http://dx.doi.org/10.1002/iju5.12031

Ejemplares similares